SCHEMBL5863620

SCHEMBL5863620

Cc1ccc(S(=O)(=O)N(Cc2ccc(O)c(C)c2)c2ccc(OCCN3CCCC3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.53
MMP9 P14780 2/20 0.53
MMP13 P45452 2/20 0.53
ADAM17 P78536 2/20 0.53
KMT2A Q03164 1/20 0.49
HRH3 Q9Y5N1 4/20 0.47
KCNH2 Q12809 1/20 0.47
CNR2 P34972 3/20 0.46
CNR1 P21554 2/20 0.46
LMNA P02545 2/20 0.45
NR3C1 P04150 1/20 0.45
ALDH1A1 P00352 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PTGES O14684 1/20 0.45
ALOX5 P09917 1/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
LTA4H P09960 1/20 0.43
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864346 0.93 MMP1 (0.51) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5863830 0.89 MMP1 (0.46) MMP1MMP9MMP13ADAM17HRH3
SCHEMBL5864219 0.89 KMT2A (0.55) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5864250 0.87 MMP1 (0.51) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5863972 0.87 LTA4H (0.48) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5864344 0.84 PGR (0.47) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5864177 0.83 MMP1 (0.54) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL5863797 0.81 MMP1 (0.61) MMP1MMP9MMP13ADAM17HRH3
SCHEMBL5863692 0.81 MMP1 (0.51) MMP1MMP9MMP13ADAM17HRH3
Hydrochloric Acid SCHEMBL5863582 0.80 MMP1 (0.60) MMP1MMP9MMP13ADAM17HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 MMP1 1746/4885MMP9 2415/4885MMP13 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.